These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

169 related items for PubMed ID: 19745119

  • 1. Redefining cancer research.
    Alberts B.
    Science; 2009 Sep 11; 325(5946):1319. PubMed ID: 19745119
    [No Abstract] [Full Text] [Related]

  • 2. Facilitating patient-centered cancer research and a new era of drug discovery.
    Niederhuber JE.
    Oncologist; 2009 Apr 11; 14(4):311-2. PubMed ID: 19365096
    [No Abstract] [Full Text] [Related]

  • 3. Factors influencing development of new therapeutics for oncology.
    Winquist RJ, Boucher DM.
    Curr Opin Pharmacol; 2010 Aug 11; 10(4):353-5. PubMed ID: 20634136
    [No Abstract] [Full Text] [Related]

  • 4. Cancer research. As questions grow, Duke halts trials, launches investigation.
    Couzin-Frankel J.
    Science; 2010 Aug 06; 329(5992):614-5. PubMed ID: 20688986
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Combining carefully selected drug, patient genetics may lead to total tumor death.
    Tuma RS.
    J Natl Cancer Inst; 2007 Oct 17; 99(20):1505-6, 1509. PubMed ID: 17925530
    [No Abstract] [Full Text] [Related]

  • 7. Disrupting cancer cells' biocircuits with interactome-based drugs: is 'clinical' innovation realistic?
    Roukos DH.
    Expert Rev Proteomics; 2012 Aug 17; 9(4):349-53. PubMed ID: 22967071
    [No Abstract] [Full Text] [Related]

  • 8. The changing landscape of cancer drug discovery: a challenge to the medicinal chemist of tomorrow.
    Pors K, Goldberg FW, Leamon CP, Rigby AC, Snyder SA, Falconer RA.
    Drug Discov Today; 2009 Nov 17; 14(21-22):1045-50. PubMed ID: 19638319
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Key drivers of biomedical innovation in cancer drug discovery.
    Huber MA, Kraut N.
    EMBO Mol Med; 2015 Jan 17; 7(1):12-6. PubMed ID: 25422355
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Man's best friend is also a friend of cancer research.
    Carter A.
    J Natl Cancer Inst; 2008 Jul 16; 100(14):984. PubMed ID: 18612124
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cancer research. Looking for a target on every tumor.
    Kaiser J.
    Science; 2009 Oct 09; 326(5950):218-20. PubMed ID: 19815749
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Developing drugs for pediatric malignancies.
    Adamson PC.
    Clin Adv Hematol Oncol; 2013 Apr 09; 11(4):227-9. PubMed ID: 23604239
    [No Abstract] [Full Text] [Related]

  • 17. Research spotlight: The Cooperative Research Centre for Cancer Therapeutics: bridging the gap between leading cancer research at Australia's universities and developing novel cancer drugs.
    Baell JB, Heathers G, Sage C.
    Future Med Chem; 2010 Jun 09; 2(6):941-7. PubMed ID: 21426113
    [No Abstract] [Full Text] [Related]

  • 18. Overview. Cancer drug discovery: pathway promise or covalent certainty for drug effect--quo vadis?
    Sausville EA.
    Curr Opin Investig Drugs; 2000 Dec 09; 1(4):511-3. PubMed ID: 11249707
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.